What's old is new again: Insights into diabetic foot microbiome.

Azza A H Rajab, Wael A H Hegazy
Author Information
  1. Azza A H Rajab: Department of Microbiology and Immunology, Faculty of Pharmacy, Zagazig University, Zagzig 44511, Egypt.
  2. Wael A H Hegazy: Department of Microbiology and Immunology, Faculty of Pharmacy, Zagazig University, Zagzig 44511, Egypt. waelmhegazy@daad-alumni.de.

Abstract

Diabetes is a chronic disease that is considered one of the most stubborn global health problems that continues to defy the efforts of scientists and physicians. The prevalence of diabetes in the global population continues to grow to alarming levels year after year, causing an increase in the incidence of diabetes complications and health care costs all over the world. One major complication of diabetes is the high susceptibility to infections especially in the lower limbs due to the immunocompromised state of diabetic patients, which is considered a definitive factor in all cases. Diabetic foot infections continue to be one of the most common infections in diabetic patients that are associated with a high risk of serious complications such as bone infection, limb amputations, and life-threatening systemic infections. In this review, we discussed the circumstances associated with the high risk of infection in diabetic patients as well as some of the most commonly isolated pathogens from diabetic foot infections and the related virulence behavior. In addition, we shed light on the different treatment strategies that aim at eradicating the infection.

Keywords

References

  1. Crit Care. 2016 Jul 11;20(1):221 [PMID: 27417949]
  2. Microorganisms. 2021 Nov 11;9(11): [PMID: 34835458]
  3. BMJ Open. 2013 Jan 04;3(1): [PMID: 23293263]
  4. Pathog Dis. 2013 Apr;67(3):159-73 [PMID: 23620179]
  5. Bioengineering (Basel). 2018 Jun 14;5(2): [PMID: 29903998]
  6. Front Cell Infect Microbiol. 2016 Nov 18;6:146 [PMID: 27917374]
  7. FEMS Immunol Med Microbiol. 2010 Mar;58(2):161-8 [PMID: 19878318]
  8. Diabetes Metab Syndr Obes. 2019 Jun 21;12:947-959 [PMID: 31417295]
  9. Med Sci (Basel). 2018 Dec 14;6(4): [PMID: 30558253]
  10. BMC Endocr Disord. 2020 Mar 20;20(1):40 [PMID: 32192488]
  11. Front Microbiol. 2021 Oct 05;12:747618 [PMID: 34675910]
  12. Microorganisms. 2021 Dec 11;9(12): [PMID: 34946165]
  13. Antimicrob Agents Chemother. 2017 Jan 24;61(2): [PMID: 27872074]
  14. J Antimicrob Chemother. 1999 Aug;44(2):263-73 [PMID: 10473234]
  15. AIMS Microbiol. 2018 Mar 30;4(2):274-288 [PMID: 31294215]
  16. Pharmaceutics. 2022 Aug 07;14(8): [PMID: 36015271]
  17. Curr Opin Microbiol. 2020 Feb;53:51-60 [PMID: 32172183]
  18. Front Cell Infect Microbiol. 2020 Aug 14;10:414 [PMID: 32923408]
  19. Bull Soc Pathol Exot. 2015 Dec;108(5):307-11 [PMID: 26187771]
  20. J Pak Med Assoc. 2017 May;67(5):665-669 [PMID: 28507348]
  21. Rev Soc Bras Med Trop. 2015 Sep-Oct;48(5):546-54 [PMID: 26516963]
  22. Curr Pathobiol Rep. 2020 Mar;8(1):1-14 [PMID: 32655983]
  23. J Appl Microbiol. 2020 Oct;129(4):860-875 [PMID: 32320111]
  24. J Clin Diagn Res. 2013 Mar;7(3):441-5 [PMID: 23634392]
  25. J Clin Microbiol. 2009 Jun;47(6):1811-7 [PMID: 19357208]
  26. Clin Infect Dis. 2008 Mar 1;46(5):647-55 [PMID: 18225981]
  27. Gene Rep. 2022 Mar;26:101495 [PMID: 35043090]
  28. Ann Med Health Sci Res. 2014 Sep;4(5):742-5 [PMID: 25328786]
  29. Antibiotics (Basel). 2021 Dec 08;10(12): [PMID: 34943720]
  30. Nat Rev Microbiol. 2015 May;13(5):269-84 [PMID: 25853778]
  31. Int Wound J. 2017 Apr;14(2):408-413 [PMID: 27212453]
  32. PLoS One. 2016 Oct 17;11(10):e0164809 [PMID: 27749921]
  33. Int J Mol Sci. 2022 Oct 28;23(21): [PMID: 36361877]
  34. Biomedicines. 2022 May 18;10(5): [PMID: 35625906]
  35. Cureus. 2016 Feb 11;8(2):e489 [PMID: 27014523]
  36. Microbiol Spectr. 2016 Apr;4(2): [PMID: 27227297]
  37. J Wound Care. 2009 Feb;18(2):54-6 [PMID: 19418781]
  38. Open Forum Infect Dis. 2014 Aug 07;1(2):ofu060 [PMID: 25734130]
  39. J Biol Chem. 2007 May 4;282(18):13592-600 [PMID: 17363368]
  40. Diabetes Res Clin Pract. 2012 Jan;95(1):153-61 [PMID: 22019426]
  41. Cochrane Database Syst Rev. 2015 Mar 06;(3):CD005083 [PMID: 25742878]
  42. Stem Cell Res Ther. 2022 Jan 8;13(1):1 [PMID: 34998430]
  43. BMC Infect Dis. 2018 Aug 2;18(1):361 [PMID: 30068306]
  44. Diagn Microbiol Infect Dis. 2014 Apr;78(4):469-80 [PMID: 24439136]
  45. World J Clin Cases. 2021 Aug 26;9(24):6969-6978 [PMID: 34540952]
  46. J R Soc Med. 2017 Mar;110(3):104-109 [PMID: 28116957]
  47. Antibiotics (Basel). 2022 Mar 30;11(4): [PMID: 35453216]
  48. Biomaterials. 2006 Jul;27(21):3934-44 [PMID: 16574218]
  49. Pathog Dis. 2020 Feb 1;78(1): [PMID: 32083661]
  50. Diagn Microbiol Infect Dis. 2008 Apr;60(4):433-6 [PMID: 18068326]
  51. PLoS One. 2019 Jan 31;14(1):e0211055 [PMID: 30703114]
  52. J Clin Microbiol. 2007 Sep;45(9):2819-28 [PMID: 17609322]
  53. J Mol Microbiol Biotechnol. 2018;28(1):37-46 [PMID: 29617701]
  54. J Wound Care. 2017 Mar 1;26(Sup3):S1-S154 [PMID: 28345371]
  55. Biomed Res Int. 2019 Apr 4;2019:2015978 [PMID: 31080810]
  56. Appl Environ Microbiol. 2015 Jul;81(13):4489-97 [PMID: 25911474]
  57. Antimicrob Agents Chemother. 2010 May;54(5):2112-8 [PMID: 20211901]
  58. J Med Microbiol. 2012 Aug;61(Pt 8):1062-1070 [PMID: 22516131]
  59. Toxins (Basel). 2016 Jul 07;8(7): [PMID: 27399775]
  60. J Cell Commun Signal. 2019 Dec;13(4):531-537 [PMID: 30903602]
  61. BMC Public Health. 2014 Oct 10;14:1059 [PMID: 25300610]
  62. Int J Microbiol. 2011;2011:605195 [PMID: 22164164]
  63. Molecules. 2022 Jan 20;27(3): [PMID: 35163939]
  64. J Med Microbiol. 2010 Oct;59(Pt 10):1219-1224 [PMID: 20595400]
  65. World J Gastrointest Pharmacol Ther. 2017 Aug 6;8(3):162-173 [PMID: 28828194]
  66. J Family Med Prim Care. 2022 Jun;11(6):3190-3195 [PMID: 36119173]
  67. FEMS Microbiol Lett. 2004 Dec 1;241(1):13-20 [PMID: 15556704]
  68. Drugs. 2010 Oct 1;70(14):1785-97 [PMID: 20836573]
  69. Pathogens. 2014 Sep 05;3(3):743-58 [PMID: 25438022]
  70. J Med Microbiol. 2014 Aug;63(Pt 8):1055-1065 [PMID: 24869663]
  71. Ann Surg. 2019 Apr;269(4):756-766 [PMID: 29099398]
  72. Clin Microbiol Infect. 2013 Sep;19(9):E398-404 [PMID: 23521557]
  73. J Clin Med. 2019 Dec 16;8(12): [PMID: 31888124]
  74. Appl Environ Microbiol. 2013 Dec;79(23):7116-21 [PMID: 24038684]
  75. Antibiotics (Basel). 2021 Jul 17;10(7): [PMID: 34356792]
  76. J Diabetes Res. 2021 Apr 27;2021:9947233 [PMID: 34007849]
  77. Int Wound J. 2011 Dec;8(6):567-77 [PMID: 21883937]
  78. Expert Opin Pharmacother. 2015 Apr;16(6):821-32 [PMID: 25736920]
  79. Arch Microbiol. 2020 Jul;202(5):953-965 [PMID: 32016521]
  80. Sci Pharm. 2016 Apr 13;84(3):484-496 [PMID: 28117314]
  81. ACS Sens. 2022 Nov 25;7(11):3416-3421 [PMID: 36351204]
  82. Folia Microbiol (Praha). 2018 Jan;63(1):115-122 [PMID: 28889401]
  83. Nanoscale Adv. 2022 Apr 11;4(11):2367-2398 [PMID: 36134136]
  84. Clin Infect Dis. 2010 Sep 15;51(6):641-50 [PMID: 20695801]
  85. Microbiol Spectr. 2019 Jul;7(4): [PMID: 31298205]
  86. EcoSal Plus. 2018 Feb;8(1): [PMID: 29424333]
  87. Endocrinol Diabetes Metab. 2021 Feb 09;4(2):e00225 [PMID: 33855224]
  88. Antimicrob Agents Chemother. 2009 Oct;53(10):4127-32 [PMID: 19635961]
  89. FEMS Microbiol Ecol. 2020 May 1;96(5): [PMID: 32109282]
  90. Nat Rev Dis Primers. 2019 Jun 13;5(1):41 [PMID: 31197153]
  91. Int J Low Extrem Wounds. 2022 Dec;21(4):364-373 [PMID: 33909495]
  92. World J Diabetes. 2017 Apr 15;8(4):135-142 [PMID: 28465790]
  93. Int Wound J. 2018 Oct;15(5):749-755 [PMID: 29869367]
  94. Nat Rev Microbiol. 2019 Jun;17(6):371-382 [PMID: 30944413]
  95. J Am Podiatr Med Assoc. 2017 Nov;107(6):483-489 [PMID: 29252023]
  96. Diabetes Res Clin Pract. 2015 Nov;110(2):147-57 [PMID: 26453263]
  97. JAMA. 1991 Sep 4;266(9):1246-51 [PMID: 1908030]
  98. J Am Podiatr Med Assoc. 2002 Jun;92(6):336-49 [PMID: 12070234]
  99. Front Biosci. 2008 Jan 01;13:1227-39 [PMID: 17981625]
  100. Diabetes Res Clin Pract. 2019 Nov;157:107843 [PMID: 31518657]
  101. Virulence. 2013 Feb 15;4(2):129-38 [PMID: 23302788]
  102. Curr Diab Rep. 2019 Aug 27;19(10):86 [PMID: 31456118]
  103. World J Diabetes. 2016 Apr 10;7(7):153-64 [PMID: 27076876]
  104. Front Med (Lausanne). 2021 Mar 31;8:524059 [PMID: 33869236]
  105. Microbiologyopen. 2020 Jan;9(1):e00946 [PMID: 31769202]
  106. Diabetes Metab Syndr. 2014 Oct-Dec;8(4):221-4 [PMID: 25311820]
  107. AIMS Microbiol. 2019 Dec 27;5(4):379-392 [PMID: 31915750]
  108. BMC Infect Dis. 2021 Aug 9;21(1):770 [PMID: 34372789]
  109. Front Pharmacol. 2016 Sep 20;7:325 [PMID: 27703432]
  110. Food Chem. 2014 Apr 1;148:453-60 [PMID: 24262582]
  111. Diabetes Metab Syndr. 2014 Jul-Sep;8(3):129-32 [PMID: 25087885]
  112. Appl Environ Microbiol. 2014 Nov;80(21):6694-703 [PMID: 25149517]
  113. J Antimicrob Chemother. 2007 Oct;60(4):819-23 [PMID: 17673476]
  114. Photodiagnosis Photodyn Ther. 2014 Sep;11(3):342-50 [PMID: 24814697]
  115. Microbiol Spectr. 2015 Oct;3(5): [PMID: 26542038]
  116. Infect Chemother. 2018 Mar;50(1):11-20 [PMID: 29637748]
  117. J Am Podiatr Med Assoc. 2015 Mar;105(2):125-9 [PMID: 25815651]
  118. J Diabetes Complications. 2016 Jul;30(5):910-6 [PMID: 26965794]
  119. BMC Infect Dis. 2021 Nov 8;21(1):1144 [PMID: 34749645]
  120. Diabet Med. 2003 Feb;20(2):159-61 [PMID: 12581269]
  121. Sci Rep. 2017 Sep 22;7(1):12222 [PMID: 28939900]
  122. mBio. 2018 May 22;9(3): [PMID: 29789364]
  123. Pathogens. 2016 Nov 30;5(4): [PMID: 27916925]
  124. Int J Infect Dis. 2017 Jun;59:61-64 [PMID: 28450198]
  125. Infect Drug Resist. 2018 Oct 10;11:1645-1658 [PMID: 30349322]
  126. J Infect Public Health. 2012 Mar;5(1):1-8 [PMID: 22341838]
  127. J Nanobiotechnology. 2018 Jan 10;16(1):2 [PMID: 29321021]
  128. Infect Immun. 2010 Jun;78(6):2834-45 [PMID: 20368347]
  129. Biofouling. 2013;29(10):1189-203 [PMID: 24067082]
  130. Biomed Res Int. 2016;2016:7616471 [PMID: 27990437]
  131. Biomed Pharmacother. 2018 Nov;107:306-328 [PMID: 30098549]
  132. Sci Adv. 2020 Nov 13;6(46): [PMID: 33188027]
  133. Nat Rev Microbiol. 2009 Aug;7(8):555-67 [PMID: 19609257]
  134. Biology (Basel). 2022 Sep 13;11(9): [PMID: 36138828]
  135. Antibiotics (Basel). 2018 Oct 02;7(4): [PMID: 30279396]
  136. Biofouling. 2016;32(2):215-25 [PMID: 26838161]
  137. Int J Mol Sci. 2022 Jan 15;23(2): [PMID: 35055129]
  138. Int J Low Extrem Wounds. 2018 Mar;17(1):14-21 [PMID: 29458291]
  139. Phys Med Rehabil Clin N Am. 2009 Nov;20(4):611-25 [PMID: 19781502]
  140. Foods. 2018 Mar 19;7(3): [PMID: 29562719]
  141. J Pak Med Assoc. 2018 May;68(5):768-772 [PMID: 29885179]
  142. Microorganisms. 2022 Jun 16;10(6): [PMID: 35744757]
  143. Microorganisms. 2022 May 18;10(5): [PMID: 35630488]
  144. Fitoterapia. 2015 Apr;102:84-95 [PMID: 25704369]
  145. Braz J Microbiol. 2021 Jun;52(2):627-638 [PMID: 33686563]
  146. Appl Environ Microbiol. 2001 Jun;67(6):2746-53 [PMID: 11375190]
  147. Antibiotics (Basel). 2021 Nov 12;10(11): [PMID: 34827323]
  148. J Pediatr Pharmacol Ther. 2010 Oct;15(4):297-300 [PMID: 22477818]
  149. Pathog Dis. 2019 Mar 1;77(2): [PMID: 30821815]
  150. J Microbiol Immunol Infect. 2007 Feb;40(1):39-44 [PMID: 17332905]
  151. Zhonghua Yi Xue Za Zhi. 2012 Jan 31;92(4):228-31 [PMID: 22490791]
  152. J Clin Diagn Res. 2017 Apr;11(4):OC25-OC28 [PMID: 28571186]
  153. Pathogens. 2022 Jun 15;11(6): [PMID: 35745541]
  154. Front Microbiol. 2018 Aug 02;9:1696 [PMID: 30116226]
  155. Pharmaceuticals (Basel). 2022 Mar 15;15(3): [PMID: 35337154]
  156. Microbiol Mol Biol Rev. 2019 Jul 17;83(3): [PMID: 31315902]
  157. Antibiotics (Basel). 2022 Nov 09;11(11): [PMID: 36358239]
  158. Medicina (Kaunas). 2019 Oct 25;55(11): [PMID: 31731539]
  159. Antibiotics (Basel). 2021 Oct 13;10(10): [PMID: 34680820]
  160. Euro Surveill. 2020 Sep;25(35): [PMID: 32885778]
  161. Pharmaceuticals (Basel). 2022 Jan 18;15(2): [PMID: 35215223]
  162. Antibiotics (Basel). 2020 Oct 03;9(10): [PMID: 33022915]
  163. J Foot Ankle Surg. 1995 Jan-Feb;34(1):61-4 [PMID: 7780395]
  164. FEMS Microbiol Lett. 2015 May;362(9): [PMID: 25837813]
  165. World J Diabetes. 2021 Nov 15;12(11):1832-1855 [PMID: 34888011]
  166. Drug Des Devel Ther. 2021 Sep 07;15:3773-3781 [PMID: 34522083]
  167. Front Med (Lausanne). 2020 Apr 21;7:131 [PMID: 32373618]
  168. Antibiotics (Basel). 2022 Jan 29;11(2): [PMID: 35203781]
  169. J Am Podiatr Med Assoc. 2014 Mar;104(2):159-68 [PMID: 24725036]
  170. Adv Wound Care (New Rochelle). 2013 Oct;2(8):438-447 [PMID: 24688830]
  171. Enferm Infecc Microbiol Clin. 2009 Jun;27(6):317-21 [PMID: 19237227]
  172. Diabetes Obes Metab. 2007 Nov;9(6):767-80 [PMID: 17924861]
  173. Front Cell Infect Microbiol. 2012 Feb 16;2:12 [PMID: 22919604]
  174. Nat Rev Microbiol. 2017 Jul;15(7):435-447 [PMID: 28420883]
  175. Microorganisms. 2022 Dec 12;10(12): [PMID: 36557708]
  176. PLoS One. 2016 Aug 24;11(8):e0161658 [PMID: 27556897]
  177. Front Cell Infect Microbiol. 2022 Jul 06;12:926758 [PMID: 35873152]
  178. BMC Res Notes. 2019 Apr 29;12(1):244 [PMID: 31036061]
  179. Antibiotics (Basel). 2019 Oct 24;8(4): [PMID: 31652990]
  180. Pathogens. 2022 Jan 03;11(1): [PMID: 35056005]
  181. Microbiol Spectr. 2022 Apr 27;10(2):e0054121 [PMID: 35234502]
  182. Sci Rep. 2014 Jun 27;4:5467 [PMID: 24970710]
  183. Front Cell Infect Microbiol. 2022 Mar 25;12:782045 [PMID: 35402300]
  184. Microorganisms. 2022 Oct 06;10(10): [PMID: 36296252]
  185. Front Microbiol. 2021 Jun 04;12:701898 [PMID: 34220788]
  186. Microorganisms. 2020 Aug 22;8(9): [PMID: 32842696]
  187. Prim Care Diabetes. 2013 Dec;7(4):303-8 [PMID: 23742849]
  188. Microorganisms. 2020 Mar 17;8(3): [PMID: 32192182]
  189. Clin Cosmet Investig Dermatol. 2022 Feb 15;15:217-235 [PMID: 35210800]
  190. Diabetes Res Clin Pract. 2022 Jan;183:109119 [PMID: 34879977]
  191. Discoveries (Craiova). 2019 Sep 30;7(3):e100 [PMID: 32309618]
  192. Int J Mol Sci. 2021 Mar 08;22(5): [PMID: 33800290]
  193. Clin Microbiol Infect. 2006 Feb;12(2):186-9 [PMID: 16441460]
  194. Front Microbiol. 2018 Sep 11;9:2127 [PMID: 30254618]
  195. FEMS Microbiol Rev. 2019 Mar 1;43(2):123-144 [PMID: 30452654]
  196. Sci Rep. 2020 May 6;10(1):7690 [PMID: 32376832]
  197. Infect Drug Resist. 2013 Nov 06;6:175-86 [PMID: 24232573]
  198. Int J Biol Macromol. 2018 Oct 15;118(Pt A):419-426 [PMID: 29908271]
  199. Microbiol Spectr. 2016 Apr;4(2): [PMID: 27227309]
  200. J Coll Physicians Surg Pak. 2016 Apr;26(4):293-6 [PMID: 27097700]
  201. Life (Basel). 2023 Jan 04;13(1): [PMID: 36676100]
  202. Front Microbiol. 2020 Oct 29;11:566325 [PMID: 33193155]
  203. Phytother Res. 2012 Sep;26(9):1371-4 [PMID: 22294419]
  204. Microbiologyopen. 2021 Jan;10(1):e1148 [PMID: 33345466]
  205. Diabetologia. 2019 Jan;62(1):3-16 [PMID: 30171279]
  206. Diabetes Metab Res Rev. 2020 Mar;36 Suppl 1:e3280 [PMID: 32176444]
  207. Arch Microbiol. 2017 Nov;199(9):1267-1275 [PMID: 28616631]
  208. Diabetes Res Clin Pract. 2021 May;175:108797 [PMID: 33845049]
  209. Gut Pathog. 2019 Feb 21;11:10 [PMID: 30828388]
  210. Int J Mol Sci. 2021 Jul 31;22(15): [PMID: 34361044]
  211. PLoS One. 2020 Apr 16;15(4):e0231625 [PMID: 32298346]
  212. J Antimicrob Chemother. 2018 Feb 1;73(2):494-502 [PMID: 29165561]
  213. J Wound Care. 2021 Jul 01;30(Sup7):S18-S27 [PMID: 34256588]
  214. Microb Biotechnol. 2016 Jan;9(1):61-74 [PMID: 26347362]
  215. Infect Immun. 2014 Apr;82(4):1616-26 [PMID: 24470471]
  216. Mayo Clin Proc Innov Qual Outcomes. 2022 May 23;6(3):250-256 [PMID: 35634135]
  217. Antimicrob Agents Chemother. 2015 Dec 28;60(3):1530-6 [PMID: 26711744]
  218. Antibiotics (Basel). 2021 Aug 21;10(8): [PMID: 34439067]
  219. Microorganisms. 2020 Oct 14;8(10): [PMID: 33066595]
  220. Lett Appl Microbiol. 2007 Sep;45(3):313-7 [PMID: 17718845]
  221. Pharmaceutics. 2021 Jan 08;13(1): [PMID: 33430162]
  222. BMC Microbiol. 2012 Nov 15;12:261 [PMID: 23153211]
  223. Microorganisms. 2021 May 18;9(5): [PMID: 34070043]
  224. Diabet Foot Ankle. 2014 Apr 10;5: [PMID: 24765246]
  225. J Bone Joint Surg Am. 2014 May 21;96(10):832-9 [PMID: 24875024]
  226. Presse Med. 2007 Jun;36(6 Pt 1):851-8 [PMID: 17329071]
  227. Saudi Med J. 2000 Apr;21(4):344-7 [PMID: 11533815]
  228. Pol J Vet Sci. 2012;15(3):431-8 [PMID: 23214361]
  229. Toxins (Basel). 2020 Sep 04;12(9): [PMID: 32899816]
  230. Int J Mol Sci. 2021 Jun 25;22(13): [PMID: 34202080]
  231. BMC Microbiol. 2019 Sep 2;19(1):204 [PMID: 31477018]
  232. J Foot Ankle Surg. 1994 Jan-Feb;33(1):91-7 [PMID: 8162001]
  233. J Allergy Clin Immunol. 2010 Feb;125(2 Suppl 2):S3-23 [PMID: 20176265]
  234. Diabetes Metab Syndr Obes. 2018 Jun 22;11:313-319 [PMID: 29950877]
  235. Med J Malaysia. 2006 Feb;61 Suppl A:14-6 [PMID: 17042222]
  236. Cochrane Database Syst Rev. 2018 Oct 17;10:CD010318 [PMID: 30328611]
  237. Surg Infect (Larchmt). 2014 Oct;15(5):585-91 [PMID: 24827989]
  238. Adv Wound Care (New Rochelle). 2019 Jul 1;8(7):341-354 [PMID: 31737421]
  239. Microbiol Mol Biol Rev. 2016 Jun 15;80(3):629-61 [PMID: 27307579]
  240. Curr Microbiol. 2020 Jun;77(6):1051-1060 [PMID: 32020464]
  241. Ann N Y Acad Sci. 2018 Jan;1411(1):153-165 [PMID: 29377202]
  242. GMS Hyg Infect Control. 2015 Feb 02;10:Doc02 [PMID: 25699225]
  243. Pharmaceuticals (Basel). 2020 Apr 01;13(4): [PMID: 32244718]
  244. Diabet Foot Ulcers Grand Chall (2021). 2022;13183:76-89 [PMID: 35465060]
  245. Curr Diab Rep. 2009 Dec;9(6):440-4 [PMID: 19954689]
  246. Antimicrob Agents Chemother. 2006 Aug;50(8):2875-9 [PMID: 16870792]
  247. J Infect Dis. 2020 Jul 21;222(Suppl 2):S119-S131 [PMID: 32691833]
  248. Onco Targets Ther. 2021 Jun 23;14:3849-3860 [PMID: 34194230]
  249. PLoS Pathog. 2022 Aug 1;18(8):e1010693 [PMID: 35914009]
  250. Cochrane Database Syst Rev. 2015 Jun 24;(6):CD004123 [PMID: 26106870]
  251. Curr Diabetes Rev. 2020;16(5):442-449 [PMID: 31657690]
  252. Tissue Cell. 2022 Jun;76:101746 [PMID: 35182986]
  253. Microb Pathog. 2020 Jan;138:103777 [PMID: 31600543]
  254. Antimicrob Agents Chemother. 2006 May;50(5):1680-8 [PMID: 16641435]
  255. Kathmandu Univ Med J (KUMJ). 2006 Jul-Sep;4(3):295-301 [PMID: 18603922]
  256. J Pathog. 2015;2015:328796 [PMID: 26843987]
  257. J Antimicrob Chemother. 2009 Dec;64(6):1212-8 [PMID: 19808232]
  258. Microbiologyopen. 2016 Oct;5(5):793-801 [PMID: 27185296]
  259. FEMS Immunol Med Microbiol. 2010 Aug;59(3):447-55 [PMID: 20528927]
  260. Int J Endocrinol. 2016;2016:8198714 [PMID: 27123004]
  261. Bacteriophage. 2011 Jan;1(1):31-45 [PMID: 21687533]
  262. Pathog Dis. 2016 Jul;74(5): [PMID: 27091004]
  263. J Appl Microbiol. 2012 Dec;113(6):1530-9 [PMID: 22985454]
  264. Yeast. 2017 Jun;34(6):253-265 [PMID: 28181315]
  265. Antibiotics (Basel). 2020 Feb 03;9(2): [PMID: 32028684]
  266. Drugs. 2021 Jan;81(1):29-56 [PMID: 33382445]
  267. Microbiol Spectr. 2015 Jun;3(3): [PMID: 26185072]
  268. Diabetes Metab. 2011 Jun;37(3):208-15 [PMID: 21169044]
  269. Diabet Med. 2004 Sep;21 Suppl 4:16-9 [PMID: 15315521]
  270. Ann Clin Microbiol Antimicrob. 2020 Jan 9;19(1):1 [PMID: 31918737]
  271. J Mater Sci Mater Med. 2018 Feb 02;29(3):22 [PMID: 29396683]
  272. Emerg Microbes Infect. 2020 Dec;9(1):1180-1193 [PMID: 32498615]
  273. Infect Drug Resist. 2019 Dec 20;12:3903-3910 [PMID: 31908502]
  274. Antibiotics (Basel). 2020 Dec 23;10(1): [PMID: 33374551]
  275. Clin Podiatr Med Surg. 2007 Jul;24(3):383-96, vii [PMID: 17613382]
  276. Antimicrob Agents Chemother. 2019 Sep 23;63(10): [PMID: 31307986]

Word Cloud

Created with Highcharts 10.0.0infectionsdiabeticfootinfectiondiabeteshighpatientsconsideredoneglobalhealthcontinuesyearcomplicationsDiabeticassociatedriskresistanceDiabeteschronicdiseasestubbornproblemsdefyeffortsscientistsphysiciansprevalencepopulationgrowalarminglevelscausingincreaseincidencecarecostsworldOnemajorcomplicationsusceptibilityespeciallylowerlimbsdueimmunocompromisedstatedefinitivefactorcasescontinuecommonseriousbonelimbamputationslife-threateningsystemicreviewdiscussedcircumstanceswellcommonlyisolatedpathogensrelatedvirulencebehavioradditionshedlightdifferenttreatmentstrategiesaimeradicatingoldnewagain:InsightsmicrobiomeBacterialbiofilmChroniculcerMethicillinresistantStaphylococcusaureusMultidrugVancomycin

Similar Articles

Cited By